IRIS
MISSO, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.125
NA - Nord America 4.336
AS - Asia 2.556
SA - Sud America 348
Continente sconosciuto - Info sul continente non disponibili 264
AF - Africa 35
OC - Oceania 5
Totale 13.669
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.257
RU - Federazione Russa 3.957
SG - Singapore 822
IT - Italia 614
IE - Irlanda 556
CN - Cina 544
VN - Vietnam 398
BR - Brasile 299
HK - Hong Kong 282
GB - Regno Unito 226
DE - Germania 222
UA - Ucraina 189
KR - Corea 148
JP - Giappone 110
FI - Finlandia 78
IN - India 66
FR - Francia 65
TR - Turchia 58
GR - Grecia 56
CA - Canada 34
PK - Pakistan 32
SE - Svezia 32
AT - Austria 18
PL - Polonia 16
BE - Belgio 15
MX - Messico 15
BD - Bangladesh 14
ES - Italia 14
CO - Colombia 13
CR - Costa Rica 13
NL - Olanda 13
IR - Iran 12
ZA - Sudafrica 12
AR - Argentina 11
CZ - Repubblica Ceca 11
ID - Indonesia 11
IQ - Iraq 11
EC - Ecuador 10
LT - Lituania 8
UZ - Uzbekistan 7
MA - Marocco 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
CH - Svizzera 5
SA - Arabia Saudita 5
AU - Australia 4
CL - Cile 4
HN - Honduras 4
IL - Israele 4
PY - Paraguay 4
RO - Romania 4
TN - Tunisia 4
TW - Taiwan 4
DK - Danimarca 3
EE - Estonia 3
JM - Giamaica 3
KE - Kenya 3
PH - Filippine 3
RS - Serbia 3
SC - Seychelles 3
TH - Thailandia 3
VE - Venezuela 3
AL - Albania 2
BO - Bolivia 2
BY - Bielorussia 2
DZ - Algeria 2
EG - Egitto 2
HU - Ungheria 2
KZ - Kazakistan 2
MD - Moldavia 2
NP - Nepal 2
OM - Oman 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
CW - ???statistics.table.value.countryCode.CW??? 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
GH - Ghana 1
GP - Guadalupe 1
GT - Guatemala 1
HT - Haiti 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
MG - Madagascar 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
Totale 13.403
Salva come PNG Salva come JPEG
Città #
Moscow 1.475
Dallas 576
Dublin 556
San Jose 477
Singapore 399
Santa Clara 347
Ashburn 332
Chandler 308
Jacksonville 300
Hong Kong 278
Council Bluffs 240
Seoul 145
Ho Chi Minh City 108
Beijing 95
New York 95
Hefei 82
Ann Arbor 81
Hanoi 79
Princeton 78
Naples 77
Dong Ket 72
Milan 72
Bremen 61
Medford 61
Roxbury 53
Boardman 51
Los Angeles 49
Caserta 42
Bengaluru 40
Aversa 38
Woodbridge 36
Munich 30
Wilmington 29
Des Moines 27
São Paulo 27
The Dalles 23
Da Nang 22
Helsinki 20
San Mateo 20
Napoli 19
Nuremberg 19
Rome 19
Warsaw 17
Orem 16
Brussels 15
Mountain View 15
San Francisco 15
Falkenstein 14
Istanbul 13
Miano 13
Cambridge 12
North Bergen 12
Phoenix 12
Tokyo 12
Brasília 11
Brno 11
Haiphong 11
Chicago 10
Frankfurt am Main 10
Houston 10
London 10
Memphis 10
Piscataway 10
San Nicola la Strada 10
Brooklyn 9
Denver 9
Johannesburg 9
Rio de Janeiro 9
Tianjin 9
Vienna 9
Zhengzhou 9
Bahawalpur 8
Chennai 8
Falls Church 8
Mexico City 8
Montreal 8
Newark 8
Boston 7
Cava Dei Tirreni 7
Düsseldorf 7
Lappeenranta 7
San José 7
Shanghai 7
Afragola 6
Belo Horizonte 6
Biên Hòa 6
Buffalo 6
Curitiba 6
Guangzhou 6
Madrid 6
Manchester 6
Nanjing 6
Viterbo 6
Amsterdam 5
Auburn Hills 5
Avellino 5
Jakarta 5
Paris 5
Philadelphia 5
Phủ Lý 5
Totale 7.475
Salva come PNG Salva come JPEG
Nome #
Comparative study of NGS platform ion torrent personal genome machine and therascreen rotor-gene Q for the detection of somatic variants in cancer. 262
Mitochondria as playmakers of apoptosis, autophagy and senescence 215
"Phase II trial of bevacizumab and dose/dense chemoterapy with cisplatin and metronomic daily oral etoposide in advanced non small cell lung cancer patients" 205
A miRNA signature suggestive of nodal metastases from laryngeal carcinoma. 205
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells 204
Long-term neuropathic pain behaviors correlate with synaptic plasticity and limbic circuit alteration: a comparative observational study in mice 201
A hydroquinone-based derivative elicits apoptosis and autophagy via activating a ros-dependent unfolded protein response in human glioblastoma 199
Anti-cancer activity of dose-fractioned mPE +/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients 198
Prognostic value of EGFR and EGFR-MEDIATED transduction signal inhibition: effective therapeutic strategies in the management of laryngeal cancer 189
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 188
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma 183
Poorly differentiated neuroendocrine larynx carcinoma: Clinical features and mirnas signature—a new goal for early diagnosis and therapy? 183
Core-shell biodegradable nanoassemblies for the passive targeting of docetaxel: features, antiproliferative activity and in vivo toxicity. 177
MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer 176
W7FW14F apomyoglobin amyloid aggregates-mediated apoptosis is due to oxidative stress and AKT inactivation caused by Ras and Rac 175
Definition of miRNA Signatures of Nodal Metastasis in LCa: miR-449a Targets Notch Genes and Suppresses Cell Migration and Invasion 174
MicroRNAs’ Crucial Role in Salivary Gland Cancers’ Onset and Prognosis 174
Immune cell infiltration and inflammatory landscape in primary brain tumours 172
Cytotoxic drugs up-regulate Epidermal Growth Factor Receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted Antibody-Dependent-Cell-mediated-Cytotoxicity (ADCC) 172
Definition of microRNAs predictive of nodal involvement in laringeal cancer patients 171
Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer 170
Gene interference strategies as a new tool for the treatment of prostate cancer 170
Combined use of free light chain and heavy/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports 169
Overview on Molecular Biomarkers for Laryngeal Cancer: Looking for New Answers to an Old Problem 166
Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer 165
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action 165
Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus 165
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 163
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 162
Advancing prognostic understanding in hepatocellular carcinoma through the integration of genomic instability and lncRNA signatures: GILncSig model 158
Bisphosphonates and cancer: what opportunities from nanotechnology? 158
Biosensore per rivelazione di firma molecolare di miRNA ad interesse diagnostico in patologie umane 157
Identification and bioinformatic characterization of a serum miRNA signature for early detection of laryngeal squamous cell carcinoma 155
Identification of Tissue miRNA Signatures for Pancreatic Ductal Adenocarcinoma 152
Impact of anemia management with EPO on psychologic distress in cancer patients: results of a multicenter patient survey. 152
Flexible 3D nanofiber-based SERS biosensor for detection of miRNA-223-3p in early Laryngeal Cancer diagnosis 151
Molecular markers as a new tool for diagnostic and prognostic definition of type 2 diabetes mellitus 151
Immune-modulating effects of bevacizumab in metastatic non-small-cell lung cancer patients 151
Emerging strategies to strengthen the anti-tumour activity of type I IFNs: overcoming survival pathways 150
null 147
Possible antioxidant role of SPA therapy with chlorine-sulphur-bicarbonate mineral water. 147
Evaluation of the in vitro and in vivo antiangiogenic effects of denosumab and zoledronic acid. 147
Radiotherapy prolongs the survival of advanced non-smallcell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev) 146
Possible roles of transglutaminases in molecular mechanisms responsible for cancer and human neurodegenerative diseases. 144
Tumour-specific uptake of anti-cancer drugs: the future is here. 143
Breast Cancer Chemotherapeutic Options: A General Overview on the Preclinical Validation of a Multi-Target Ruthenium(III) Complex Lodged in Nucleolipid Nanosystems 141
Emerging pathways as individualized therapeutic target of multiple myeloma. 139
Nanoparticelle e loro usi 138
Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment 138
Tissue expression of miR-449a as risk factor for occult neck metastasis in patients with cT3-T4 N0 laryngeal cancer. A pilot study 137
Transferrin-Conjugated SNALPs Encapsulating 2'-O-Methylated miR-34a for the Treatment of Multiple Myeloma 137
Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse 137
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 135
Insight toward the microRNA profiling of laryngeal cancers: Biological role and clinical impact 134
High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. 133
Measurement of autophagy by flow cytometry 133
Long non-coding RNAs as important biomarkers in laryngeal cancer and other head and neck tumours 133
Nanocarriers Conjugated with Cell Penetrating Peptides: New Trojan Horses by Modern Ulysses 132
MOLECULAR TARGETS FOR THE TREATMENT OF MULTIPLE MYELOMA 131
Immune-modulating Effects of the Newest Cetuximab-based Chemoimmunotherapy Regimen in Advanced Colorectal Cancer Patients. 131
Mir-34: a new weapon against cancer? 129
Optimal Management of Prostate Cancer Based on its Natural Clinical History 129
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics 128
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. 127
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin 127
Early detection of laryngeal cancer: prominence of miRNA signature as a new tool for clinicians 127
Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum 127
Myrtucommulone production by a strain of Neofusicoccum australe endophytic in myrtle (Myrtus communis). 126
Lipid Nanoparticles to Deliver miRNA in Cancer 126
Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment 126
Pharmacological inhibition of HSP90 and ras activity as a new strategy in the treatment of HNSCC. 125
In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma. 124
Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells. 122
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: The GOLFIG-2 multicentric open-label randomized phase III trial 120
Synergistic activity of everolimus and 5-aza-2'-deoxycytidine in medullary thyroid carcinoma cell lines 119
Role of perineural invasion as a prognostic factor in laryngeal cancer 117
The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response 117
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 117
Hepatocarcinoma: genetic and epigenetic features 112
Therapeutic targeting of miR-29b/HDAC4 epigenetic loop in multiple myeloma 110
MICRO-RNAs as biological markers for prevention and diagnosis of oral carcinomas 110
Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review 106
Interleukin-2 and lanreotide in the treatment of medullary thyroid cancer: in vitro and in vivo studies. 106
Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research 106
Non-coding RNAs as a new dawn in tumor diagnosis 106
Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection 105
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(Iii) complex with superior anticancer bioactivity 105
Proteomic profiling identifies miR-423-5p as a modulator of oncogenic metabolism in HCC 103
Complex genetic landscape in CLL: Clinical impact on patients’ survival and insights into the altered molecular pathways 100
Aminobisphosphonates and nano technologically-modified aminobisphosphonates: A new dawn in the treatment of bone and extra-bone tumors? 99
Prognostic patterns for predicting lymph node metastasis in patients with squamous cell carcinoma of the larynx 97
MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interaction 96
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 95
miRNA–lncRNA Cross-Regulation Landscape in Cancer: From Molecular Mechanisms to Therapeutic and Diagnostic Applications 50
Ferroptosis Among the Antiproliferative Pathways Activated by a Lipophilic Ruthenium(III) Complex as a Candidate Drug for Triple-Negative Breast Cancer 21
p63 and ZNF148 cooperate to regulate head and neck squamous cell carcinoma 18
Electrochemical liquid biopsy across cancer care pathway 18
microRNA Detection via Nanostructured Biochips for Early Cancer Diagnostics 17
Totale 13.669
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.035
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022408 0 0 0 7 147 11 6 14 18 25 43 137
2022/20231.138 125 19 18 118 104 121 4 63 506 19 23 18
2023/2024645 35 15 90 29 148 82 7 23 37 9 46 124
2024/20251.464 27 31 6 85 232 195 209 119 226 117 123 94
2025/20267.342 280 388 859 281 568 3.671 384 334 188 236 100 53
2026/20271.124 47 148 495 434 0 0 0 0 0 0 0 0
Totale 13.669